In conclusion, this study demonstrated that GNG5 was overexpressed in gliomas and significantly associated with clinicopathologic characteristics and molecular subtypes, suggesting that it was a subtype‐associated gene in the molecular classification of gliomas. The gene discussed is GNG5; the disease is glioma.